Meloxicam in Tanzania: NEMLIT level, who can prescribe it and STG references

Meloxicam is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level D (regional referral hospital). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 8 or more sections.

Last updated

New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.

Is meloxicam available on the DukaDawa pharmacy network?

Not yet. Meloxicam is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.

Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.

Is meloxicam on the NEMLIT, and who can prescribe it?

Yes. Meloxicam is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level D (regional referral hospital). At level D it may be prescribed by specialists, medical officers and dental officers.

Level
D (regional referral hospital)
Category
Non-opioids and Non-steroidal Anti-inflammatory Medicines (NSAIMs) (Medicines for Pain and Palliative Care)
Listed forms
Tablet 7.5mg; 15mg
Page
NEMLIT, p. 4
Who may prescribe at each NEMLIT level (STG/NEMLIT 7th edition, Part I, Table 1). Levels listed for this medicine are highlighted.
LevelFacilityWho may prescribe
ADispensarySpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer
BHealth centreSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer
CCouncil or district hospitalSpecialist, Medical Officer, Dental Officer, Assistant Medical Officer
D (listed)Regional referral hospitalSpecialist, Medical Officer, Dental Officer
SZonal, special and national hospitalsSpecialist

A medicine is listed from the lowest facility level where it should be available.

Where is meloxicam in the Standard Treatment Guidelines?

The Standard Treatment Guidelines (7th edition, 2026) mention meloxicam in 8 or more sections, most often section 16.31.1 Temporal Mandibular Disorder and Chronic Orofacial Pain > Temporomandibular Disorders (TMDs) (p. 429). See the STG for treatment details.

  • 16.31.1 Temporal Mandibular Disorder and Chronic Orofacial Pain > Temporomandibular Disorders (TMDs), p. 429
  • 17.2.1 Inflammatory condition > Osteoarthritis, p. 439
  • 17.2.3 Inflammatory condition > Tendinopathies, p. 440
  • 17.2.4 Inflammatory condition > Plantar Fasciitis, p. 441
  • 17.3.1 Metabolic Bone Diseases > Osteoporosis and Brittle Bone Diseases, p. 442
  • 18.9 Ligament rupture, p. 458
  • 26.1.1 Inflammatory Arthritis > Rheumatoid Arthritis (RA), p. 711
  • 26.1.2 Inflammatory Arthritis > Psoriatic Arthritis (PsA), p. 713

Sections that mention Meloxicam, most mentions first. Positions only: see the STG for treatment details.

All non-opioids and non-steroidal anti-inflammatory medicines (nsaims) on the NEMLIT

Sources

  • Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania

Page last updated

STG positions are section numbers and printed page numbers only.

This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.

For licensed prescribers and pharmacists. Not medical advice. Check the Standard Treatment Guidelines before prescribing.